Investigational Combination Shows Promise in Chronic Hepatitis D
https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c
(MedPage Today) — WASHINGTON — An investigational dual therapy appeared to show antiviral activity in patients with chronic hepatitis D virus (HDV) infection, according to the phase II SOLSTICE trial. At week 24, the combined alanine response…
:max_bytes(150000):strip_icc()/Health-GettyImages-1195240877-86e59b16af3d47569699ef9ef1f78074.jpg?w=390&resize=390,220&ssl=1 "Can You Eat Brown Avocado?")